virus neutralizing monoclonal antibody therapeutics (Integrated BioTherapeutics/Mapp Biopharmaceutical)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevirus neutralizing monoclonal antibody therapeutics (Integrated BioTherapeutics/Mapp Biopharmaceutical)
Drug Alias Namealphavirus antibodies
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsChikungunya FeverAlphavirus InfectionsEncephalitis, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntegrated Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsChikungunya FeverAlphavirus InfectionsEncephalitis, Viral

Other Information

ATC CodeN/A
Related LinksN/A